Uncoupling protein-1 (UCP) is uniquely expressed in brown adipose tissue (BAT) and is essential to the thermogenic function of this tissue. The UCP gene is under the control of norepinephrine (NE) via cAMP. However, the precise delineation of the cAMP response sequences and mechanisms whereby cAMP stimulate the gene have remained elusive. A BAT tumor cell line, HIB-1B, can be differentiated into UCP-expressing brown adipocytes. We report here that when these cells are differentiated with a standard differentiation protocol including insulin, T 3 , hydrocortisone, IBMX, and indomethacin (standard differentiation, StD), cAMP stimulation of the rat UCP gene is largely mediated by an upstream 90-bp sequence -2,399/-2,490 (R90) with a lesser contribution of a downstream sequence -57/ϩ114 (dnCRS). This latter is functional also in non-BAT cells, whereas the cAMP response sequence contained in R90 (upCRS) is BAT-specific. Thiazolidinediones (TZD) are a new group of drugs known to increase sensitivity to insulin and, more recently, to induce adipocyte differentiation (adipogenesis) via PPAR␥. A TZD, darglitazone (darg), can rapidly induce differentiation of HIB-1B cells, as judged by the expression of the adipocyte lipid binding protein (aP2), lipoprotein lipase (LPL), uncoupling protein (UCP) and ␤ 3 -adrenergic receptors. UCP messenger RNA (mRNA) responsive to NE is evidenced as early as one day after exposure to darg. While UCP-CAT vectors (ϩ114/ Ϫ3673 bp of rat UCP gene) are barely responsive to NE in HIB-1B preadipocytes, both darg and StD markedly enhance NE responsiveness of such constructs. However, by 3 days of exposure to darg, the responses were less vigorous than in StD cells (4-to 10-fold vs. 20-to 50-fold), and the deletion of R90 did not affect the response to NE in darg-differentiated cells, whereas this deletion caused a 75% reduction in StD cells. Prolongation of darg exposure to 5-7 days resulted in greater response of UCP mRNA to NE and 50 -80% inhibition of the response of UCP-CAT vectors by the deletion of R90. Thus, darginduced differentiation of HIB-1B cells suggests that the NE-dependent expression of the UCP gene takes place in a step-wise manner: first, the gene is "enabled," as no UCP mRNA is detected in HIB-1B preadipocytes; thereafter and transiently, the response of the gene to NE is sustained by dnCRS; finally, as differentiation progresses, a cell-specific and more powerful cis-acting sequence, upCRS, is recruited, accounting in the fully differentiated cell for most of the response to NE. These results also suggest that TZDs might increase energy expenditure by inducing terminal differentiation of BAT, and that these drugs may be useful in the differential cloning of the factors involved in the recruitment of the BAT specific cAMP response sequence. (Endocrinology 138: [5325][5326][5327][5328][5329][5330][5331][5332] 1997) 
as one day after exposure to darg. While UCP-CAT vectors (ϩ114/ Ϫ3673 bp of rat UCP gene) are barely responsive to NE in HIB-1B preadipocytes, both darg and StD markedly enhance NE responsiveness of such constructs. However, by 3 days of exposure to darg, the responses were less vigorous than in StD cells (4-to 10-fold vs. 20-to 50-fold), and the deletion of R90 did not affect the response to NE in darg-differentiated cells, whereas this deletion caused a 75% reduction in StD cells. Prolongation of darg exposure to 5-7 days resulted in greater response of UCP mRNA to NE and 50 -80% inhibition of the response of UCP-CAT vectors by the deletion of R90. Thus, darginduced differentiation of HIB-1B cells suggests that the NE-dependent expression of the UCP gene takes place in a step-wise manner: first, the gene is "enabled," as no UCP mRNA is detected in HIB-1B preadipocytes; thereafter and transiently, the response of the gene to NE is sustained by dnCRS; finally, as differentiation progresses, a cell-specific and more powerful cis-acting sequence, upCRS, is recruited, accounting in the fully differentiated cell for most of the response to NE. These results also suggest that TZDs might increase energy expenditure by inducing terminal differentiation of BAT, and that these drugs may be useful in the differential cloning of the factors involved in the recruitment of the BAT specific cAMP response sequence. (Endocrinology 138: 5325-5332, 1997) B ROWN AND WHITE adipose tissues have diametrically opposed effects in energy balance. While white adipose tissue (WAT) serves as storage of calories ingested in excess, brown adipose tissue (BAT) dissipates energy as heat in response to cold or excessive caloric intake. The major difference revolves around the capacity of BAT to uncouple phosphorylation, a function ultimately due to the uncoupling protein uniquely expressed in this tissue (1) . Recently, two other uncoupling protein complementary DNAs (cDNAs), termed 2 and 3, with a more ubiquitous tissue distribution have been cloned, but the function of the corresponding gene products has not yet been defined (2, 3) . Uncoupling protein-1 (UCP), the product of BAT-specific uncoupling protein-1 gene, determines its thermogenic potential and is essential for cold adaptation, as the targeted disruption of this gene causes the loss of this adaptive response (4) .
The expression of the UCP-1 gene is under complex regulation. BAT sympathetic stimulation, via norepinephrine (NE) and cAMP, is the primary signal to activate its expression but other factors, such as thyroid hormone, are critical for a full physiological response (recently reviewed in Ref. 5) . In spite of the progress made in the knowledge of the regulation of the expression this gene, still the sequences and mechanisms whereby cAMP stimulates the gene are poorly understood. In the mouse UCP gene, Kozak et al. (6) identified several potential cAMP response elements (CRE) of which the most important is located upstream in the gene in a 210-bp enhancer called "activator element" by the group of Ricquier (7) in the rat UCP gene. Notably, in this latter, it has not been possible to define cAMP response sequences (5, 7). The major difficulty in defining this aspect of the gene regulation has been the lack of suitable experimental models.
We have in recent years witnessed rapid progress in the understanding of adipose tissue differentiation or adipogenesis (8) . A number of observations in this rapidly expanding field are relevant to the studies reported here. The early stages of the adipogenic programs appear to be common to WAT and BAT. At least in these early stages of adipogenesis, the peroxisome proliferator-activated receptor gamma (PPAR␥), more specifically PPAR␥2 (9, 10) seems to play a critical role. Additional interest in these receptors has come from the observation that the insulin-sensitizing drugs thiazolidinediones (TZD) bind specifically to PPAR␥ (11, 12) . Most importantly, these drugs show that PPAR␥2 may also participate in the terminal differentiation of BAT. The TZD pioglitazone accelerates UCP messenger RNA (mRNA) appearance in cultured brown adipocytes precursors and increases BAT weight and UCP mRNA content in ob/ob and C57ϩ/ϩ mice (13) , whereas the TZD BRL49653 given to adult CD1 rats increases BAT weight but not UCP mRNA concentration (14) . These, and the early observations that TZDs can increase energy expenditure in rodents (15, 16) suggest that they may stimulate both terminal BAT differentiation and function. TZDs have also been reported to differentiate HIB-1B cells (17, 18), a BAT cell line derived from a mouse hibernoma generated by transgenic expression of the SV40 early region genes (19, 20) .
HIB-1B cells exposed to TZDs could thus provide a useful model to unravel terminal differentiation of BAT, the recruitment of the UCP regulatory elements and the identification of the CRE(s). Characterizing the effect of the TZD darglitazone (darg) on the differentiation and UCP expression in HIB-1B cells, we have made interesting observations regarding the sequences involved in the stimulation of the rat UCP gene by cAMP. Results reported here suggest that the acquisition of the full expression of UCP and its responsiveness to NE occurs in a step-wise manner during differentiation and that at least two sequences participate in the mediation of cAMP stimulation of the rat UCP gene, one located in the minimal promoter and another, more powerful and tissue specific, located in a complex upstream enhancer element. Not only these results are important with regard to the regulation of the UCP gene but the capacity of TZDs to affect BAT function and differentiation adds an interesting dimension to the potential therapeutic of these drugs.
Materials and Methods

Cell culture
HIB-1B preadipocytes (gift from Dr. B. Spiegelman) were cultured in DMEM (high glucose, no sodium pyruvate) supplemented with 10% FBS (Wysent), and maintained in a 10% CO 2 incubator at 37 C. They were differentiated following two different protocols, namely, standard differentiation and darglitazone (darg) differentiation. Standard differentiation was induced essentially as described (19). Briefly, cells were grown in the so called adipocyte medium (DMEM ϩ 10% FBS in the presence of 18 nm insulin and 1 nm T 3 ). When they reached tight confluence, they were refed with the same medium supplemented with 0.5 mm isobutylmethyl-xantine (IBMX), 0.5 m hydrocortisone and 0.125 mm indomethacin. Three days later, cells were placed back in adipocyte medium and incubated for additional 5 days at the end of which they attained differentiation, as assessed by their ability to express UCP (19). The darg differentiation was induced, as the name indicates, with the thiazolidinedione darglitazone (Pfizer). This drug was used at the concentration of 30 m, known to be nontoxic and maximally stimulate glucose transport in 3T3-L1 cells (M. Gibbs, Pfizer, personal communication). This differentiation was performed as recently described for another thiazolidinedione (18), with some modifications. First, cells were plated at high density in DMEM ϩ 10% charcoal-dextran stripped serum (cds-FBS) and allowed to become confluent (usually 6 -12 h later). At confluence, 30 m darg or the same volume of its solvent, dimethyl-sulfoxide (DMSO; final Յ0.1%), was added for 1 to 7 days, as indicated along with the experiments described. After differentiation, the adipogenic media were substituted by fresh medium containing either plain FBS or cds-FBS, as appropriate, and cells were exposed to various experimental conditions, as described with the individual experiments. Cells were then harvested for mRNA analysis or transfected with various UCP-CAT expression vectors. JEG-3 and CHO cells were cultured as described previously (21).
Transient transfection assays
Differentiated or nondifferentiated HIB-1B cells as well as JEG-3 or CHO cells were transfected by the calcium phosphate method as described previously (21). The preadipocytes were transfected at 80 -90% confluence, and the differentiated HIB were transfected at the end of the either of the specific differentiation protocols described above. After darg differentiation, cells were placed in fresh DMEM-cds-FBS and trans- 
RNA analysis
Total RNA was isolated from cultured HIB-1B pre-adipocytes and adipocytes by a popular acid guanidinium thiocyanate-phenol-chloroform extraction method previously described (25). Five or 10 g of RNA were denatured in formamide and formaldehyde and electrophoresed in agarose gels for Northern blotting, following published guidelines (26). Ethidium bromide staining, probing with an 18S rRNA or GAPDH specific oligonucleotide was used to control for equivalence of RNA loading. cDNAs probes for rat UCP, mouse PPAR␥ 2 (gift from Dr. B. Spiegelman), and mouse aP2 and LPL (gift of Dr. V. Giguère) were labeled with [␣-32 P]dCTP and/or [␣-32 P]dATP by the random primer method (27). Other probes were commercially available and equally labeled.
Statistical analysis
Results are expressed as mean Ϯ sem. Significance was assessed by the Student's t test or ANOVA, followed by Newman-Keul's test for the comparison of multiple means within an experiment. Some Northern blots were quantified using the ImageQUant software (Molecular Dynamics, Sunnyvale, CA).
Results
Effect of darglitazone on HIB-1B cells differentiation and expression of UCP
In agreement with previous observations in HIB-1B cells treated with the TZD BRL49653 (14) , or in primary cultures of rat brown preadipocytes treated with another TZD, pioglitazone (13), we find that cells exposed to darg become round and acquire refringent droplets by phase contrast in 2-3 days, which are morphological indicators of differentiation (data not shown). Figure 1 depicts the most salient results regarding the acquisition of UCP expression. Cells were exposed to darg or the darg diluent dimethyl sulfoxide (DMSO) for the indicated times. After the induction period, cells were challenged with various adrenergic agonists and antagonists for 4 h, as indicated, after which they were harvested and the RNA probed for UCP, aP2 or LPL mRNAs. Note first in panels A and C of Fig. 1 that, regardless of the exposure to darg, there was not detectable UCP mRNA ex-pression unless the cells were stimulated with an adrenergic agent, suggesting that darg per se does not significantly stimulate UCP expression. This was corroborated in RNA obtained immediately after the incubation with darg as well as by acutely adding the drug after the induction period (data not shown). In The presence of both receptors explain the greater response to NE than to CL, as the former binds and activates are ␤-ARs, whereas CL is a pure ␤ 3 -AR agonist. Figure 1C shows the time dependency of the darg effect on UCP, aP2 and LPL mRNAs. While within 1 day there was evidence of adipose differentiation, as judged by the markers of adipogenesis, the response of UCP mRNA was delayed, consistent with this being a later event in the process of brown adipose differentiation. Thus, aP2 and LPL nearly reached a plateau within a day of exposure to darg, whereas the response of UCP mRNA to NE was very weak at 1 day and not detectable for CL. By 2 days the response to NE was vigorous and that to CL clear, yet weaker than that to NE. Note, finally that neither adrenergic agent stimulated the expression of aP2 or LPL during this short exposure. Altogether, these results indicate that darg stimulates both the basal adipogenesis and the brown-adipocyte specific adipogenic program in HIB-1B cells as it makes the UCP gene responsive to NE and other adrenergic agonists. Both ␤ 1 -AR and ␤ 3 -AR seem to be present as in mature brown adipocytes (28).
A possibility to explain the lack of effect of NE on UCP mRNA in nondifferentiated HIB-1B cells is the lack of one or more steps in the NE signaling pathway. To test this possibility, we transfected HIB-1B preadipocytes with either SS-70-CAT, a reporter vector containing the promoter and cAMP response element of the somatostatin gene (30), or with 3.7 UCP-CAT, a reporter expression vector driven by the 3.7 kb of 5Ј-flanking sequence of the rat UCP gene. As shown in Fig. 2 both constructs responded to NE, 8-Br-cAMP and forskolin indicating the presence of an intact NE signaling pathway. The lack of UCP mRNA expression in HIB-1B preadipocytes is thus due to other mechanism, probably repression of the gene expression or lack of a factor necessary to enable the UCP gene. The difference in CAT activity between 3.7 UCP-CAT and SS-70-CAT probably reflects the greater strength of the somatostatin promoter in HIB-1B preadipocytes because ␤-galactosidase expression was the same in cells transfected with either CAT vector (data not shown).
Sequences involved in the responses of UCP to NE
The stimulation of CAT by NE and other adrenergic agonists in HIB-1B preadipocytes transfected with 3.7 UCP-CAT suggests that the BAT phenotype is not necessary for the responsiveness. We previously reported that UCP-CAT constructs could respond to adrenergic stimulation in JEG-3 cells (21) but the sequences involved were not defined. In a recent review (5), we reported unpublished results indicating that in differentiated HIB-1B most of the response to cAMP was mediated by 90 bp between Ϫ2,490/Ϫ2,399 contained in a critical enhancer previously identified in the mouse (6) and in the rat (7) UCP genes. This enhancer area showed cellspecificity and the need of mature BAT phenotype for expression. The experiment depicted by Fig. 3A shows that in JEG-3 cells the sequence mediating cAMP response, in this case stimulated by forskolin, is located in the minimal promoter of the UCP gene. Similar results (not shown) were obtained in CHO cells. These observations suggest that the 90 bp, Ϫ2490/Ϫ2,399, called by us R90 as it also contains a complex retinoic acid response element (23), contributes little or nothing to the cAMP response in these cells. In contrast, in differentiated HIB-1B cells, but not in JEG-3 cells, the upstream enhancer can confer responsiveness to cAMP to a CAT vector driven by the thymidine kinase promoter (Fig.  3B) . Figure 4 shows two additional aspects of the UCP gene response to NE in HIB-1B cells. Panel A shows the effect of time of exposure to darg. The response to a 4-h challenge with NE approaches a plateau by 5 days of exposure to the darg. Note again that there was no detectable UCP mRNA in the cells not stimulated with NE. In panel B, we show the response of cells exposed for 3 days to darg in comparison to that of cells differentiated with the standard protocol. The response to NE of these latter cells was about three times more vigorous.
A possibility to explain these results is that the cAMP response sequences are recruited sequentially during the process of differentiation. The results depicted in Figs. 5 and 6 suggest that this is likely the case. In Fig. 5 we have compared UCP-CAT constructs responses to NE in cells exposed to darg for 3 days with standard differentiated cells. The response of the intact 3.7 UCP-CAT construct to NE in standard differentiated cells was much more vigorous, over 20-fold, and the deletion of R90 caused approximately a 75% drop in the response. In contrast, in darg-differentiated cells the response of 3.7 UCP-CAT was weaker, about 6 fold, not different from that in nondifferentiated cells (Fig. 3) , the deletion of R90 did not affect the response, and, moreover, the response mediated by the minimal promoter Ϫ57/ϩ114 was not significantly different from that of the other constructs. These observations indicate that by 3 days of exposure to darg the response of UCP mRNA to cAMP is mediated largely by the downstream cAMP response sequence (dnCRS) contained in the minimal promoter of the gene, whereas standard differentiated cells have recruited the upstream cAMP response sequence (upCRS) contained in R90. When the exposure to darg was prolonged, however, the contribution of upCRS became evident, as illustrated in Fig.  6 . These are two representative experiments wherein darg exposure was prolonged for up to 10 days. After 3 days of darg, the deletion of R90 had no effect on the CAT response to NE, in agreement with the results just described, whereas after 5 days of darg this deletion was associated with 50 -80% drop in the response. More prolonged exposure to darg, in charcoal-dextran strip serum, results in cell deterioration and reduced efficiency of transfection so that basal CAT expression in the cells transfected with 3.7 ⌬90 UCP-CAT was too low to calculate accurately the fold stimulation (hence the label "error" in the figure) . Results of two other experiments in darg-differentiated cells compared with cells differentiated with the standard protocol are summarized in Fig. 7 . Results have been expressed as percent fall in the response to NE with the deletion of R90, and the days on darg have been averaged. During the first days of darg exposure, the deletion of R90 has no effect on the response to NE, whereas in standard differentiated cells the average drop in the response to NE with such deletion was 72%. After 4.7 days in darg the drop in response caused by the deletion of R90 averaged 55%, but as shown in other experiments, e.g. Fig. 6 , it could be as much as 80%.
Discussion
We have studied the effects of a TZD, darglitazone or darg, on HIB-1B cells. Our focus has been the terminal differen- tiation of these cells, i.e. the acquisition of the essential feature of the BAT phenotype that is the expression of UCP. We find, as other authors have reported previously, that these drugs can induce or accelerate the acquisition of BAT phenotype by HIB-1B preadipocytes (14, 18) . In the present studies, we have compared the differentiation induced by darg with that induced by standard adipogenic protocols including hormones and factors previously shown to induce white adipocyte differentiation as well as differentiation of HIB-1B cells (20, 31) . Within a day of exposure, darg brings up the expression of adipogenic markers such as aP2 and LPL and makes the UCP gene responsive to NE. The responsiveness to NE of UCP mRNA is time dependent, approaching a plateau between 5 and 7 days. Parallel transient transfections studies suggest that the responsiveness of the gene to NE can be mediated by sequences far apart in the gene: a downstream cAMP response sequence between Ϫ57/ϩ114 (dnCRS) and an upstream sequence between Ϫ2,490/Ϫ2,399 (upCRS), contained in a critical sequence of the gene called by us R90 (23). The former is non-BAT specific, as it can be demonstrated in JEG-3 and CHO cells as well as in HIB-1B preadipocytes, whereas upCRS requires the mature BAT phenotype. Furthermore, these two sequences are not recruited simultaneously. The data suggest that dnCRS is enabled even before differentiation, whereas upCRS is recruited later, after 4 -5 days of darg induction.
The mechanism of action of TZDs in adipogenesis is being the focus of intensive investigation, but there is consensus that these drugs act as ligands of PPAR␥ [ (8, 32, 33) for recent reviews]. It is possible that ligand-activated PPAR␥s stimulate the expression of other key adipogenic gene products, such as C/EBP␣ (8 -10, 34, 35) , but these receptors could also act directly on some of the genes encoding adipose tissue proteins, for example aP2, which can be directly stimulated by liganded PPAR␥ (36) . Even though the details have to await further research, it is reasonable to postulate that TZDs can induce adipose differentiation by regulating both the expression of key regulatory genes, as well as by directly affecting the expression of gene products responsible for the mature adipose phenotype, via PPAR response elements (PPREs) yet to be defined. How could these drugs bring about terminal differentiation of brown adipocytes?
The UCP gene is expressed uniquely in BAT [the expression of the gene in skeletal muscle of KK yellow mice reported by Nagase et al. (37) will need reevaluation in the light of the newly discovered, more ubiquitous uncoupling protein-2 (2) or -3 (3)]. This is probably the result of gene repression in non-BAT tissues and brown adipocytes precursors. Such repression would be removed sometime during the process of differentiation of these cells. The mechanism of repression probably involves the concealing in the chromatin of the upstream enhancer described in the mouse and rat genes between approximately Ϫ2.28/Ϫ2.49 kb (6, 7), because a DNAse-I hypersensitive has been identified in this area, in chromatin from mature brown adipocytes but not in nuclei from other cells or tissues (38) . In addition to the exposure of this specific part of the gene sequence, probably trans-acting factors are also necessary to bring about the expression of the gene. TZDs could enable the expression of the UCP gene and its stimulation by cAMP either by facilitating the exposure of this critical sequence, by inducing some critical transactivation factor or both, all of which is matter of active research in our laboratory.
In addition to enabling the expression of the UCP gene, does darg directly stimulate the UCP gene? Our results show that, in the absence of an adrenergic agonist, there is no detectable levels of UCP mRNA after exposing the cells for as long as 10 days to darg suggesting that drug does not directly stimulates the gene. This is in apparent contradiction with the reports by Graves and colleagues indicating that TZDs stimulate reporter gene expression driven by UCP gene sequences in HIB-1B preadipocytes (14, 18 ). However, it should be noted that these authors did not examine the response in differentiated HIB-1B cells nor did they examine the effect of acutely added thiazolidinediones on UCP mRNA levels. In agreement with them, we find that darg acutely added to HIB-1B preadipocytes can stimulate reporter gene expression mediated by upstream UCP gene sequences, and we also find a putative PPRE in R90, but the responsiveness is lost when the cells have entered the process of differentiation (data not shown). Besides, as shown here, darg alone does not increase UCP mRNA to a detectable level. Thus, there is no evidence this far that TZDs directly stimulate the UCP gene expression in differentiated adipocytes and our results are better interpreted as indicating that these drugs enable the expression of the gene by mechanisms to be determined, and probably also induce transactivating factors involved in the recruitment of upCRS, as discussed below.
The results reported here suggest that to make the gene fully responsive to NE, the recruitment of two cAMP response sequences is necessary. In transient transfection studies on the rat UCP gene, Cassard-Doulcier et al. obtained modest and variable responses to cAMP or adrenergic receptor agonists with virtually all their constructs spanning 4.2 kb of 5Ј flanking region, but no discrete sequence was deemed to be or contain a CRE (7). With transient transfection assays, Kozak et al. (5) found that, out of four possible CREs, two of them, CREs 2 and 4, were probably important for NE responses of the mouse of UCP gene. While CRE4, located in the minimal promoter was necessary for NE stimulation (its mutation reduced the responses by Ͼ90%), this sequence in isolation could not confer significant cAMP responses. This was interpreted as this sequence being "required for a promoter function" rather than being a cAMPdependent enhancer. Only CRE2, located in between approximately Ϫ2,400 and Ϫ2,500, could confer cAMP responsiveness to both homologous and heterologous promoters (6). Our results are similar but not identical to those obtained by these authors. The upCRS is located in the same area of the gene where Kozak et al. (6) localized their CRE2. As this latter, upCRS requires the mature brown fat phenotype to be recruited and accounts for most (70 -80%) of the responsiveness of the gene to cAMP in mature cells, although not as much as in the mouse gene (Ͼ90%). At variance with the results obtained by Kozak et al. (6) , our data suggest that the CRE contained in dnCRS is more important than they estimated and can be considered a bona fide cAMP-dependent enhancer. Thus, we find it can sustain up to 25-30% of the reporter gene response in fully differentiated cells and seemingly is responsible for the NE-induced increase in UCP mRNA before any evidence of recruitment of the upstream element is available.
Altogether, our findings are consistent with the model we proposed in a recent review (5) . According to this model, cAMP responses of the UCP mRNA gene would be mediated by two of several possible CRE motifs found in the 5Ј flanking sequence of the gene. The downstream one (in dnCRS), is not cell specific, weaker and probably activated by CREB, as its response closely parallels that of the somatostatin promoter (Fig. 2) , and the overexpression of CREB enhances the response in JEG-3 cells (data not shown). The upstream CRE contained in upCRS or R90, is cell specific, stronger, and activated by a cell-specific protein alone or in conjunction with CREB. The induction of such a protein could be a direct or an indirect effect of PPAR␥2 activation by TZDs or endogenous ligands such as certain prostaglandins (39) . Our data further suggest that upCRS recruitment may be facultative, in contrast to dnCRS which is enabled in HIB-1B preadipocytes as well as differentiated cells. Being the CRE contained in upCRS a stronger one, the facultative recruitment may be of importance in the responses of the tissue to stimulation. Endogenous ligands, such as those just mentioned, could play a critical role in the recruitment of this regulatory element. This is an area that deserves further study.
Certainly the potential of TZDs to differentiate committed precursors into brown adipocytes adds another perspective to the clinical use of these drugs. For one thing, this is consistent with early observations that TZDs stimulate energy expenditure in lean and obese rodents (15, 16) . This effect of these drugs might explain the observation in human trials that the use of troglitazone has not been thus far associated with an increase in weight or adiposity (40 -43) , even though the drug is clearly adipogenic and stimulates the expression of lipogenic enzymes. It will be critical to study the effect of these drugs on resting energy expenditure in humans. Another implication of the present results is that TZDs and HIB-1B cells could serve as a potentially valuable model to unravel the factors involved in the expression of UCP and in the cell-specific regulation by cAMP. Such a model has not been available, which explains our limited knowledge in this area in spite of the gene being cloned nearly ten years ago (44, 45) . 16 Identification of a cyclic-AMP-responsive element within the rat somatostatin gene. Proc Natl Acad Sci USA 83:6682-6686
